Erlotinib and Gemcitabine in Treating Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline and/or a Taxane
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: erlotinib hydrochloride|DRUG: gemcitabine hydrochloride
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)